Calculating absolute copy numbers in cancer genome sequences identifies disease-associated genes and provides insights into tumor evolution and heterogeneity.
References
Carter, S.L. et al. Nat. Biotechnol. 30, 413–421 (2012).
Kallioniemi, A. et al. Science 258, 818–821 (1992).
Bignell, G.R. et al. Nature 463, 893–898 (2010).
Beroukhim, R. et al. Nature 463, 899–905 (2010).
Popova, T. et al. Genome Biol. 10, R128 (2009).
Van Loo, P. et al. Proc. Natl. Acad. Sci. USA 107, 16910–16915 (2010).
Yau, C. et al. Genome Biol. 11, R92 (2010).
Nik-Zainal, S. et al. Cell 149, 994–1007 (2012).
Gerlinger, M. et al. N. Engl. J. Med. 366, 883–892 (2012)
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Van Loo, P., Campbell, P. ABSOLUTE cancer genomics. Nat Biotechnol 30, 620–621 (2012). https://doi.org/10.1038/nbt.2293
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.2293
- Springer Nature America, Inc.
This article is cited by
-
Genomically personalized therapy in head and neck cancer
Cancers of the Head & Neck (2016)
-
Ploidy-Seq: inferring mutational chronology by sequencing polyploid tumor subpopulations
Genome Medicine (2015)
-
BACOM2.0 facilitates absolute normalization and quantification of somatic copy number alterations in heterogeneous tumor
Scientific Reports (2015)
-
Leveraging a Multi-Omics Strategy for Prioritizing Personalized Candidate Mutation-Driver Genes: A Proof-of-Concept Study
Scientific Reports (2015)
-
Cancer genomics: one cell at a time
Genome Biology (2014)